Ann Arbor Hematoloty-Oncology

Ann Arbor, Michigan 48106

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Renal Cell Carcinoma

Studies at this site

• CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC) — Completed